The dual impact of GLP-1 receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials.

RPEP-114242025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
The dual impact of GLP-1 receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials.
Published In:
Therapeutic advances in endocrinology and metabolism, 16, 20420188251383064 (2025)
Database ID:
RPEP-11424

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-11424·https://rethinkpeptides.com/research/RPEP-11424

APA

Hoteit, Bassel H; Kotaich, Jana; Ftouni, Hadi; Hazime, Fatima; Safawi, Abdallah; Masri, Rim; Marwani, Mia. (2025). The dual impact of GLP-1 receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials.. Therapeutic advances in endocrinology and metabolism, 16, 20420188251383064. https://doi.org/10.1177/20420188251383064

MLA

Hoteit, Bassel H, et al. "The dual impact of GLP-1 receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials.." Therapeutic advances in endocrinology and metabolism, 2025. https://doi.org/10.1177/20420188251383064

RethinkPeptides

RethinkPeptides Research Database. "The dual impact of GLP-1 receptor agonists on metabolic and ..." RPEP-11424. Retrieved from https://rethinkpeptides.com/research/hoteit-2025-the-dual-impact-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.